Ambrose, J.A., Barua, R.S. (2004). The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol, 43 (10), 1731-1737. doi:10.1016/j.jacc.2003.12.047

Australian Bureau of Statistics (2013). Australian Health Survey: Biomedical Results for Chronic Diseases, 2011-2012, cat. no. 4364.0.55.003, ABS, Canberra. Retrieved from http://www.abs.gov.au

Australian Bureau of Statistics (2015). National Health Survey, First results 2014-15, cat. no. 4364.0.55.001, ABS, Canberra. Retrieved from http://www.abs.gov.au

Australian Institute of Health and Welfare (AIHW). (2017). Trends in cardiovascular deaths. Retrieved from https://www.aihw.gov.au

Australian Institute of Health and Welfare (AIHW). (2018). Data tables: Cardiovascular disease 2018. AIHW, Canberra. Retrieved from https://www.aihw.gov.au

Briffa, T., Hickling, S., Knuiman, M., Hobbs, M., Hung, J., Sanfilippo, K., ... Thompson, P. (2009). Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005. BMJ, 338(7690). doi:10:1136/bmj.b36

Castelli, W.P. (1984). Epidemiology of coronary heart disease: The Framingham Study. Amer J. Med, 76 (2, Part A), 4-12. doi:10.1016/0002-9343(84)90952-5

Chapman, S., Byrne, F., & Carter, S.M. (2003). "Australia is one of the darkest markets in the world": the global importance of Australian tobacco control. Tobacco Control, 12 (s3): 1-3. doi:10.1136/tc.12.suppl_3.iii1

Chipty, T. (2016). Study of the impact of the Tobacco Plain Packaging Measure on Smoking prevalence in Australia. Retrieved from http://www.health.gov.au

Collins, R., Peto, R., MacMahon, S., Hebert, P., Fiebach, N.H., Godwin, J., ... Hennekens, C.H. (1990). Blood pressure, stroke , and coronary heart disease. Part 2, short-term reductions in blood pressure: an overview of randomised drug trials in their epidemiological context. Lancet , 335 (8693), 827-838. doi:10.1016/0140-6736(90)90944-Z

Dawber, T.R., Meadors, G.F., & Moore FE. (1951). Epidemiological approaches to heart disease: The Framingham Study. Amer J Public Health, 41 (3), 279-286. doi:10.2105/AJPH.41.3.279

Dawber, T.R., Moore, F.E., & Mann, G.V. (1957). Coronary heart disease in the Framingham Study. Am J Pub Health Nations Health, 47 (4 Pt 2), 4-24. doi:10.2105/AJPH.47.4_Pt_2.4

Department of Health. (2018). National Tobacco Campaign. Retrieved October 29, 2018 from http://www.health.gov.au

Dobson, A.J. (1987). Trends in cardiovascular risk factors in Australia 1966-1983; evidence from prevalence surveys. Community Health Studies, 1 (1), 2-14. doi:10.1111/j.1753-6405.1987.tb00125.x

Dwyer, T., & Hetzel, B.S. (1980). A comparison of trends of coronary heart disease mortality in Australia, USA and England and Wales with reference to three major risk factors - hypertension, cigarette smoking and diet. Int J Epidem, 9 (1), 65-71. doi:10.1093/ije/9.1.65

Ettehad, D., Emdin, C.A., Kiran, A., Anderson, S.G., Callendar, T., Emberson, J., ... Rahimi, K. (2016). Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet, 387 (10022), 957-967. doi:10.1016/S0140-6736(15)01225-8

Goble, A.J., Sloman, G., & Robinson, J.S. (1966). Mortality Reduction in a Coronary Care Unit. BMJ, 1 (5494), 1005–1009. doi:10.1136/bmj.1.5494.1005

Gofman, J.W., Lindgren, F., Elliott, H., Mantz, W., Hewitt, J., Strisower, B., ... Lyon, T.P. (1950). The Role of Lipids and Lipoproteins in Atherosclerosis. Science, 111(2877), 166-186. doi:10.1126/science.111.2877.166

Gofman, J.W., Hanig, M., Jones, H.B., Lauffer, M.A., Lawry, E.Y., Lewis, L.A., ... White, P.D. (1956). Evaluation of serum lipoprotein and cholesterol measurements as predictors of clinical complications of atherosclerosis: report of a cooperative study of lipoproteins and atherosclerosis. Circulation, 14 (4 Part 2), 691-741. Retrieved from http://www.ovid.com

Goldberg, R.J., Yarzebski, J., Lessard, D., & Gore, J.M. (1999). A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol 33(6), 1533-1539. doi:10.1016/S0735-1097(99)00040-6

Commonwealth Department of Health and Aged Care. (1999). Australian Statistics on Medicines 1998. Retrieved from http://www.pbs.gov.au

Heart Foundation. (2012). Reducing risk in heart disease. Retrieved from https://www.heartfoundation.org.au

Heart Foundation. (2016). Guideline for the diagnosis and management of hypertension in adults. Retrieved from https://www.heartfoundation.org.au

Hess, C.N., Wang, C.C.L., & Hiatt, W.R. (2018). PCSK9 Inhibitors: mechanisms of action, metabolic effects and clinical outcomes. Ann Review Medicine, 69, 133-145. doi:10.1146/annurev-med-042716-091351

Julian, D.G. (2001). The evolution of the coronary care unit. Cardiovascular Research 51(4), 621-624. doi:10.1016/S0008-6363(01)00365-0

Katz, L.N., Allen, E.V., Cherkovsky, M., Davis, F.W., & Dawber, T.R. (1960). Cigarette smoking and cardiovascular disease: Report by the American Heart Foundation. Circulation, 22, 160-166.

Killip, T., & Kimball, J.T. (1967). Treatment of myocardial infarction in a coronary care unit: A two year experience with 250 patients. Amer J Cardiol, 20(4), 457-464. doi:10.1016/0002-9149(67)90023-9

Kontos, M.C., Rennyson, S.L., Chen, A.Y., Alexander, K.P., Peterson, E.D., & Roe, M.T. (2014). The association of myocardial infarction process of care measures and in-hospital mortality: a report from the NCDR . Am Heart J, 168 (5), 766-775. doi:10.1016/j.ahj.2014.07.005

Law, M.R., Wald, N.J., & Rudnika, A.R. (2003). Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ, 326, 1423. doi:10.1136/bmj.326.7404.1423

Lintott, C.J., Scott, R.S., Nye, E.R., Robertson, M.C., & Sutherland, W.H.F. (1989). Simvastatin (MK733): an effective treatment for hypercholesterolaemia. Aust NZ J Med, 19 (4): 317-320. doi:10.1111/j.1445-5994.1989.tb00270.x

Lloyd-Jones, D.M., Leip, E.P., Larson, M.G., D'Agostino, R.B., Beiser, A., Wilson, P.W., ... Levy, D. (2006). Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation, 113(6), 791-798. doi:10.1161/CIRCULATIONAHA.105.548206

Lloyd-Jones, D.M., Morris, P.B., Ballantyne, C.M., Bircher, K.K., Daly, D.D., DePalmer, S.M., ... Smith, S.C. (2016). 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk. J Am Coll Cardiol, 68 (1), 92-125. doi:10.1016/j.jacc.2016.03.519

Mabott, V & Storey, P. (2016). Australian Statistics on Medicines, 2015. Pharmaceutical Benefits Division. Retrieved from http://www.pbs.gov.au

Mach, F., Ray, K.K., Wiklund, O., Corsini, A., Catapano, A.L., Bruckert, E., ... Chapman, M.J. (2018). Adverse effects of statin therapy: perception vs. the evidence- focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Europ Heart J, 39(27), 2526-2539. doi:10.1093/eurheartj/ehy182

Mahmood ,S., Levy, D., Vasan, R.S., & Wang, T. (2014). The Framingham Heart Study and the epidemiology of cardiovascular diseases: A historical perspective. Lancet, 383 (9921), 999-1008. doi:10.1016/S0140-6736(13)61752-3

Moser, M. (2006). Historical perspectives on the management of hypertension. J Clin Hypert, 8 (s8), 15-20. doi:10.1111/j.1524-6175.2006.05836.x

Mundith, E.D., Buckley, M.J., Daggett, W.M., Sanders, C.A., & Austen, W.G. (1972). Surgery for complications of acute myocardial infarction. Circulation, 45 , 1279-1291. Retrieved from http://www.ovid.com

National Vascular Disease Prevention Alliance (NVDPA). (2012). Guidelines for the management of absolute cardiovascular disease risk. Retrieved from https://www.heartfoundation.org.au

Organization for Economic Co-operation and Development (OECD). (2016). Health care quality indicators, acute care, 30-day mortality after admission to hospital for AMI based on admission data. Retrieved on 29 October, 2018 from https://stats.oecd.org

O'Flaherty, M., Allender, S., Taylor, R., Stevenson, C., Peeters, A., & Capewell, S. (2012). The decline in coronary heart disease mortality is slowing in young adults (Australia 1976-2006): a time trend analysis. Int J Cardiol, 158(2),193-198. doi:10.1016/j.ijcard.2011.01.016

O'Rourke, M.F., Chang, V.P., Windsor, H.M., Shanahan, M.X., Hickie, J.B., Morgan, J.J., ... Harrison, D.G. (1975). Acute severe cardiac failure complicating myocardial infarction. Experience with 100 patients referred for consideration of mechanical left ventricular assistance. Br Heart J, 37, 169-181. Retrieved from https://www.semanticscholar.org

Rapsomaniki, E., Timmis, A., George, J., Pujades-Rodriguez, M., Shah, A.D., Denaxas, S., ... Hemingway, H. (2014). Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost. And age-specific associations in 1.25 million people. Lancet, 383 (9932),1899-1911. doi:10.1016/S0140-6736(14)60685-1

Scollo, M.M., & Winstanley, M.H. (2012). Tobacco in Australia: Facts and issues (4th ed.). Cancer Council Victoria. https://www.tobaccoinaustralia.org.au

Schaffer A.L., Buckley, N.A., Dobbins T.A., Banks, E., & Pearson, S. (2016). The crux of the matter: Did the ABC's Catalyst program change statin use in Australia? Med J Aust 202 (11), 591-591. doi:10.5694/mja15.00103

Thompson, P., & Sloman, G. (1971). Sudden death in hospital after discharge from coronary care unit. BMJ, 4,136-139. Retrieved from https://www.semanticscholar.org

Tunstall-Pedoe, H. (1999). Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. The Lancet, 353 (9164), 1547-1557. doi:10.1016/S0140-6736(99)04021-0

White, V., & Williams, T. (2015). Australian school students' use of tobacco in 2014. Centre for Behavioural Research in Cancer, Cancer Council Victoria. Retrieved from http://www.nationaldrugstrategy.gov.au

Woodward, S.D. (1984). Trends in Cigarette Consumption in Australia. Australian and New Zealand Journal of Medicine 14 (4), 405-407. doi: 10.1111/j.1445-5994.1984.tb03604.x

Yeh, R.W., Sydney, S., Chandra M., Sorel, M., Selby, J.V., & Go, A.S. (2010). Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med, 362(23), 2155-2164. doi:10.1056/NEJMoa0908610